Trodelvy 180 MG vials
Ended Awarded
- Contract number
- SPE2DB25FJH13
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,585
Award facts
- Contract value 100% obligated
- $9,584.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $9,584.58 to AmerisourceBergen Drug Corp for the supply of Trodelvy 180 mg vials under firm fixed price terms. The contract is non-competitive and was executed on August 8, 2025, with an ultimate completion date of August 29, 2025. AmerisourceBergen Drug Corp will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued against the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026.
As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contracts with the Defense Logistics Agency covering a broad spectrum of pharmaceutical products, medical devices, and specialized healthcare commodities. Trodelvy, a cancer therapeutic indicated for certain metastatic cancers, represents the type of specialized medication consistent with the company's role in supporting the Defense Health Agency and other federal healthcare systems. This delivery order exemplifies the operational execution of the broader pharmaceutical prime vendor relationship that enables efficient procurement of critical medical supplies across the military healthcare enterprise.
Quick answers
Who was awarded contract SPE2DB25FJH13?
SPE2DB25FJH13 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FJH13 worth?
The government has obligated $9,585 on SPE2DB25FJH13.
Is contract SPE2DB25FJH13 an order under another contract?
Yes. SPE2DB25FJH13 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJH13 competed?
The extent of competition for SPE2DB25FJH13 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award